DD151059A5 - Neue peptide und verfahren zu ihrer herstellung - Google Patents
Neue peptide und verfahren zu ihrer herstellung Download PDFInfo
- Publication number
- DD151059A5 DD151059A5 DD80219646A DD21964680A DD151059A5 DD 151059 A5 DD151059 A5 DD 151059A5 DD 80219646 A DD80219646 A DD 80219646A DD 21964680 A DD21964680 A DD 21964680A DD 151059 A5 DD151059 A5 DD 151059A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- phe
- trp
- thr
- lys
- solution
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/065—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for hydroxy functions, not being part of carboxy functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/16—Somatostatin; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH250679 | 1979-03-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
DD151059A5 true DD151059A5 (de) | 1981-09-30 |
Family
ID=4235326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD80219646A DD151059A5 (de) | 1979-03-16 | 1980-03-13 | Neue peptide und verfahren zu ihrer herstellung |
Country Status (17)
Country | Link |
---|---|
US (1) | US4316890A (fr) |
EP (1) | EP0017760B1 (fr) |
JP (1) | JPS55124748A (fr) |
KR (1) | KR830001872A (fr) |
AT (1) | ATE3283T1 (fr) |
AU (1) | AU5646280A (fr) |
CA (1) | CA1140117A (fr) |
DD (1) | DD151059A5 (fr) |
DE (1) | DE3063028D1 (fr) |
ES (1) | ES489565A0 (fr) |
FI (1) | FI800795A (fr) |
GR (1) | GR67655B (fr) |
IL (1) | IL59620A (fr) |
NO (1) | NO800743L (fr) |
NZ (1) | NZ193129A (fr) |
PT (1) | PT70951A (fr) |
ZA (1) | ZA801520B (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4499079A (en) * | 1982-11-18 | 1985-02-12 | E. R. Squibb & Sons, Inc. | Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides |
US4612302A (en) * | 1983-11-14 | 1986-09-16 | Brigham And Women's Hospital | Clinical use of somatostatin analogues |
US5504069A (en) * | 1993-02-11 | 1996-04-02 | Biomeasure, Inc. | Inhibition of trauma-induced tumor growth |
US5965698A (en) * | 1993-04-23 | 1999-10-12 | Virginia Commonwealth University | Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site |
US5928896A (en) * | 1993-04-23 | 1999-07-27 | Virginia Commonwealth University | Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site |
US5952465A (en) * | 1993-04-23 | 1999-09-14 | Virginia Commonwealth University | Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site |
WO1994025482A1 (fr) * | 1993-04-23 | 1994-11-10 | Evans Herbert J | Polypeptides comprenant des groupes contraignant la conformation qui sont adjacents a un site d'interaction proteine-proteine |
US6258550B1 (en) | 1993-04-23 | 2001-07-10 | Virginia Commonwealth University | Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site |
US6084066A (en) * | 1993-10-29 | 2000-07-04 | Virginia Commonwealth University | Polypetides that include conformation-constraining groups which flank a protein-protein interaction site |
US5597894A (en) * | 1995-06-05 | 1997-01-28 | The Louisiana State University Medical Center Foundation | Multi-tyrosinated somatostatin analogs |
EP0981364B1 (fr) * | 1997-05-13 | 2006-03-01 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Procede et compositions pour traiter l'hyperlipidemie |
US6004928A (en) * | 1997-05-13 | 1999-12-21 | Biomeasure, Incorporated | Method of treating hyperlipidemia |
ES2216290T3 (es) * | 1997-05-13 | 2004-10-16 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Somatostatina y agonistas de la somatostatina para el tratamiento de insensibilidad a la insulina y de sindrome x. |
AU7655098A (en) | 1997-05-13 | 1998-12-08 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Somatostatin and somatostatin agonists for decreasing body weight |
US5968903A (en) * | 1998-05-07 | 1999-10-19 | Biomeasure, Incorporated | Inhibition of H. pylori proliferation |
PT2062914E (pt) | 2001-06-08 | 2014-07-18 | Ipsen Pharma Sas | Análogos quiméricos de somatostatina-dopamina |
EP2161037A3 (fr) | 2003-04-22 | 2010-05-26 | Ipsen Pharma | Conjugués de Camptothecin-Somatostatin |
US20110171191A1 (en) | 2008-06-12 | 2011-07-14 | Syntaxin Limited | Suppression of neuroendocrine diseases |
US10240138B2 (en) | 2008-06-12 | 2019-03-26 | Ipsen Bioinnovation Limited | Polypeptides that bind to and inhibit secretion from growth hormone secreting cells |
GB0820970D0 (en) | 2008-11-17 | 2008-12-24 | Syntaxin Ltd | Suppression of cancer |
JP6869720B2 (ja) | 2013-06-13 | 2021-05-12 | アンチセンス セラピューティクス リミテッド | 併用療法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4020157A (en) * | 1975-07-08 | 1977-04-26 | Ayerst Mckenna And Harrison Ltd. | Shortened analogs of somatostatin |
US4372884A (en) * | 1975-08-06 | 1983-02-08 | The Salk Institute For Biological Studies | Pharmaceutically active peptides |
NL7607987A (nl) * | 1975-08-08 | 1977-02-10 | Merck & Co Inc | Werkwijze voor het bereiden van peptiden. |
US4122077A (en) * | 1976-12-17 | 1978-10-24 | American Home Products Corporation | Somatostatin analogs |
US4098782A (en) * | 1977-03-14 | 1978-07-04 | American Home Products Corporation | (His5)-somatostatin and analogues thereof |
US4115554A (en) * | 1977-08-29 | 1978-09-19 | Merck & Co., Inc. | Somatostatin analogs |
GB2019411B (en) * | 1978-04-24 | 1982-06-16 | American Home Prod | Peptides related to somatostatin |
-
1980
- 1980-03-10 US US06/129,066 patent/US4316890A/en not_active Expired - Lifetime
- 1980-03-13 AT AT80101310T patent/ATE3283T1/de not_active IP Right Cessation
- 1980-03-13 DD DD80219646A patent/DD151059A5/de unknown
- 1980-03-13 EP EP80101310A patent/EP0017760B1/fr not_active Expired
- 1980-03-13 DE DE8080101310T patent/DE3063028D1/de not_active Expired
- 1980-03-14 CA CA000347728A patent/CA1140117A/fr not_active Expired
- 1980-03-14 IL IL59620A patent/IL59620A/xx unknown
- 1980-03-14 ES ES489565A patent/ES489565A0/es active Granted
- 1980-03-14 FI FI800795A patent/FI800795A/fi not_active Application Discontinuation
- 1980-03-14 ZA ZA00801520A patent/ZA801520B/xx unknown
- 1980-03-14 NO NO800743A patent/NO800743L/no unknown
- 1980-03-14 PT PT70951A patent/PT70951A/pt unknown
- 1980-03-14 AU AU56462/80A patent/AU5646280A/en not_active Abandoned
- 1980-03-14 GR GR61450A patent/GR67655B/el unknown
- 1980-03-14 JP JP3170980A patent/JPS55124748A/ja active Pending
- 1980-03-14 NZ NZ193129A patent/NZ193129A/xx unknown
- 1980-03-15 KR KR1019800001097A patent/KR830001872A/ko unknown
Also Published As
Publication number | Publication date |
---|---|
NZ193129A (en) | 1982-06-29 |
DE3063028D1 (en) | 1983-06-16 |
IL59620A0 (en) | 1980-06-30 |
CA1140117A (fr) | 1983-01-25 |
ZA801520B (en) | 1981-03-25 |
ES8103028A1 (es) | 1981-02-16 |
FI800795A (fi) | 1980-09-17 |
AU5646280A (en) | 1980-09-18 |
JPS55124748A (en) | 1980-09-26 |
ATE3283T1 (de) | 1983-05-15 |
US4316890A (en) | 1982-02-23 |
NO800743L (no) | 1980-09-17 |
ES489565A0 (es) | 1981-02-16 |
IL59620A (en) | 1983-07-31 |
EP0017760B1 (fr) | 1983-05-11 |
KR830001872A (ko) | 1983-05-19 |
PT70951A (en) | 1980-04-01 |
EP0017760A1 (fr) | 1980-10-29 |
GR67655B (fr) | 1981-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0023192B1 (fr) | Cyclopeptides et compositions pharmaceutiques les contenant ainsi que procédé pour leur préparation et leur utilisation | |
DD151059A5 (de) | Neue peptide und verfahren zu ihrer herstellung | |
EP0001295B1 (fr) | Cyclopeptides analogues à la somatostatine, procédé pour leur préparation, compositions pharmaceutiques les contenant et leur application thérapeutique | |
EP0030920B1 (fr) | Acylpeptides et leurs préparations pharmaceutiques, ainsi que leur préparation et leur application | |
EP0083305B1 (fr) | Octapeptides cycliques, préparations pharmaceutiques les contenant et procédés de leur préparation et leur utilisation | |
DE3853384T2 (de) | Peptid. | |
EP0031303A2 (fr) | Cyclooctapeptides et leurs préparations pharmaceutiques, procédé pour leur préparation et leur application | |
DE69101187T2 (de) | VIP-Analogen und ihre Verwendung. | |
DD156968A5 (de) | Verfahren zur herstellung von neuen angiotensin-ii antagonisierenden oktapeptidestern | |
CH629475A5 (de) | Verfahren zur herstellung von polypeptiden. | |
DE3326472A1 (de) | Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus | |
DE3333640A1 (de) | Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung | |
DE69003595T2 (de) | Mikroproteine, Verfahren zur Herstellung derselben und Anwendung dieser Mikroproteine als Arzneimittel. | |
DE69426270T2 (de) | Hgh-rh(1-29)nh2 analoge mit antagonistischer aktivität | |
DE2635558A1 (de) | Somatostatinanaloge | |
DE3875765T2 (de) | Fluor enthaltende atriale natriuretische peptide. | |
DE60218199T2 (de) | Humane wachstumshormone freisetzende hormonanaloge, deren herstellung und verwendung | |
DE2633976A1 (de) | Tripeptidderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel | |
EP0003028B1 (fr) | Analogues de la bêta h-endorphine, préparations les contenant et leur procédé de préparation | |
DD217808A5 (de) | Verfahren zur herstellung von saeugetier-pgrf | |
DE3883649T2 (de) | Therapeutische Analoga von Somatostatin. | |
DE2423549A1 (de) | Verfahren zur herstellung von cystinhaltigen peptiden | |
DE69032591T2 (de) | Physiologisch aktive peptide und den calcium-metabolismus regulierende arzneimittel, die genannte peptide als wirkungsvollen bestandteil enthalten | |
CH632486A5 (de) | Verfahren zur herstellung von tetradecapeptiden. | |
EP0596350B1 (fr) | Cyclopeptides |